Silo Pharma, Inc.: INTRACOASTAL CAPITAL, LLC amends Schedule 13G stake filing
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
IntraCoastal Capital LLC amended its Schedule 13G stake filing for Silo Pharma, Inc., according to SEC accession 0001213900-26-118165. The filing updates the investor's reported position in the pharmaceutical company, though the article did not disclose the specific number of shares or percentage owned. Schedule 13G amendments are typically filed by passive investors to reflect changes in beneficial ownership. The revision matters because it signals a shift in IntraCoastal's holdings that could affect Silo Pharma's shareholder base. Investors will watch for the updated ownership figures in the filing itself and any subsequent 13G amendments for further position changes.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
Silo Pharma, Inc., Intracoastal Capital, LLC